WATSON 240 0.5 (Lorazepam 0.5 mg)

Pill imprint WATSON 240 0.5 has been identified as Lorazepam 0.5 mg.

Lorazepam is used in the treatment of anxiety; borderline personality disorder; insomnia; panic disorder; cervical dystonia (and more), and belongs to the drug classes benzodiazepine anticonvulsants, benzodiazepines, miscellaneous antiemetics. There is positive evidence of human fetal risk during pregnancy. Lorazepam 0.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Lorazepam

Imprint:

WATSON 240 0.5

Strength:

0.5 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Benzodiazepine anticonvulsants
Benzodiazepines
Miscellaneous antiemetics

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

4 - Some potential for abuse

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

00591-0240

Inactive Ingredients:

lactose
magnesium stearate
microcrystalline cellulose
polacrilin potassium

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
63739-0499	McKesson Packaging Services
55045-1372	Dispensing Solutions Inc. (repackager)
16590-0143	Stat RX USA LLC (repackager)
66336-0363	Dispensing Solutions Inc. (repackager)
66267-0133	Nucare Pharmaceuticals Inc (repackager)
43063-0057	PDRX Pharmaceuticals Inc (repackager)
55289-0402	PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.